vs
Healthpeak Properties（DOC）与康宝莱（HLF）财务数据对比。点击上方公司名可切换其他公司
康宝莱的季度营收约是Healthpeak Properties的1.7倍（$1.2B vs $702.9M），Healthpeak Properties净利率更高（51.6% vs 5.0%，领先46.6%），康宝莱同比增速更快（7.8% vs -6.6%），过去两年Healthpeak Properties的营收复合增速更高（0.5% vs -2.3%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
康宝莱是美国跨国多层次营销企业，主营膳食补充剂的研发与销售。该公司曾被指控涉嫌金字塔骗局欺诈运营，2016年与美国证监会达成协议后调整了薪酬体系，将经销商奖励与可核实的实际销售额挂钩。此外其部分产品曾被曝出引发急性肝炎的相关问题。
DOC vs HLF — 直观对比
营收规模更大
HLF
是对方的1.7倍
$702.9M
营收增速更快
HLF
高出14.5%
-6.6%
净利率更高
DOC
高出46.6%
5.0%
两年增速更快
DOC
近两年复合增速
-2.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $1.2B |
| 净利润 | $363.0M | $61.2M |
| 毛利率 | — | 84.0% |
| 营业利润率 | 0.7% | 11.3% |
| 净利率 | 51.6% | 5.0% |
| 营收同比 | -6.6% | 7.8% |
| 净利润同比 | 28.3% | 21.4% |
| 每股收益（稀释后） | $0.28 | $0.57 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCHLF
| Q1 26 | $702.9M | $1.2B | ||
| Q4 25 | $719.4M | $1.3B | ||
| Q3 25 | $705.9M | $1.3B | ||
| Q2 25 | $694.3M | $1.3B | ||
| Q1 25 | $702.9M | $1.2B | ||
| Q4 24 | $698.0M | $1.2B | ||
| Q3 24 | $700.4M | $1.2B | ||
| Q2 24 | $695.5M | $1.3B |
净利润DOCHLF
| Q1 26 | $363.0M | $61.2M | ||
| Q4 25 | $114.0M | $85.4M | ||
| Q3 25 | $-117.1M | $43.2M | ||
| Q2 25 | $31.7M | $49.3M | ||
| Q1 25 | $42.8M | $50.4M | ||
| Q4 24 | $4.5M | $177.9M | ||
| Q3 24 | $85.9M | $47.4M | ||
| Q2 24 | $146.0M | $4.7M |
毛利率DOCHLF
| Q1 26 | — | 84.0% | ||
| Q4 25 | — | 77.5% | ||
| Q3 25 | 58.6% | 77.7% | ||
| Q2 25 | 60.2% | 78.0% | ||
| Q1 25 | 61.1% | 78.3% | ||
| Q4 24 | 60.3% | 77.8% | ||
| Q3 24 | 60.0% | 78.3% | ||
| Q2 24 | 60.6% | 77.9% |
营业利润率DOCHLF
| Q1 26 | 0.7% | 11.3% | ||
| Q4 25 | 17.4% | 7.8% | ||
| Q3 25 | 9.2% | 9.9% | ||
| Q2 25 | 5.7% | 10.5% | ||
| Q1 25 | 7.7% | 10.1% | ||
| Q4 24 | -2.2% | 8.8% | ||
| Q3 24 | 14.1% | 10.2% | ||
| Q2 24 | 22.3% | 6.3% |
净利率DOCHLF
| Q1 26 | 51.6% | 5.0% | ||
| Q4 25 | 73.2% | 6.7% | ||
| Q3 25 | -16.6% | 3.4% | ||
| Q2 25 | 4.6% | 3.9% | ||
| Q1 25 | 6.1% | 4.1% | ||
| Q4 24 | 0.7% | 14.7% | ||
| Q3 24 | 12.3% | 3.8% | ||
| Q2 24 | 21.0% | 0.4% |
每股收益（稀释后）DOCHLF
| Q1 26 | $0.28 | $0.57 | ||
| Q4 25 | $0.16 | $0.81 | ||
| Q3 25 | $-0.17 | $0.42 | ||
| Q2 25 | $0.05 | $0.48 | ||
| Q1 25 | $0.06 | $0.49 | ||
| Q4 24 | $0.02 | $1.75 | ||
| Q3 24 | $0.12 | $0.46 | ||
| Q2 24 | $0.21 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $451.2M |
| 总债务越低越好 | — | $2.0B |
| 股东权益账面价值 | $7.8B | — |
| 总资产 | $21.6B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCHLF
| Q1 26 | $-1.2B | $451.2M | ||
| Q4 25 | $467.5M | $353.1M | ||
| Q3 25 | $91.0M | $305.5M | ||
| Q2 25 | $89.4M | $320.9M | ||
| Q1 25 | $70.6M | $329.4M | ||
| Q4 24 | $119.8M | $415.3M | ||
| Q3 24 | $180.4M | $402.5M | ||
| Q2 24 | $106.9M | $374.0M |
总债务DOCHLF
| Q1 26 | — | $2.0B | ||
| Q4 25 | $9.8B | $2.0B | ||
| Q3 25 | $9.1B | $2.0B | ||
| Q2 25 | $9.0B | $2.1B | ||
| Q1 25 | $8.9B | $2.2B | ||
| Q4 24 | $8.7B | $2.3B | ||
| Q3 24 | $8.6B | $2.3B | ||
| Q2 24 | $8.6B | $2.3B |
股东权益DOCHLF
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $-515.1M | ||
| Q3 25 | $7.6B | $-612.0M | ||
| Q2 25 | $7.9B | $-660.5M | ||
| Q1 25 | $8.2B | $-736.0M | ||
| Q4 24 | $8.4B | $-801.1M | ||
| Q3 24 | $8.6B | $-954.2M | ||
| Q2 24 | $8.8B | $-1.0B |
总资产DOCHLF
| Q1 26 | $21.6B | $2.9B | ||
| Q4 25 | $20.3B | $2.8B | ||
| Q3 25 | $19.6B | $2.7B | ||
| Q2 25 | $19.8B | $2.7B | ||
| Q1 25 | $19.8B | $2.7B | ||
| Q4 24 | $19.9B | $2.7B | ||
| Q3 24 | $20.0B | $2.7B | ||
| Q2 24 | $20.2B | $2.6B |
负债/权益比DOCHLF
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $113.8M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | — | 1.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCHLF
| Q1 26 | — | $113.8M | ||
| Q4 25 | $1.3B | $98.3M | ||
| Q3 25 | $315.0M | $138.8M | ||
| Q2 25 | $363.5M | $96.0M | ||
| Q1 25 | $279.4M | $200.0K | ||
| Q4 24 | $1.1B | $69.6M | ||
| Q3 24 | $318.2M | $99.5M | ||
| Q2 24 | $316.2M | $102.5M |
自由现金流DOCHLF
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $79.8M | ||
| Q3 25 | — | $118.0M | ||
| Q2 25 | — | $73.2M | ||
| Q1 25 | — | $-18.1M | ||
| Q4 24 | $333.7M | $43.9M | ||
| Q3 24 | — | $72.4M | ||
| Q2 24 | — | $66.2M |
自由现金流率DOCHLF
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | 6.2% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | — | 5.8% | ||
| Q1 25 | — | -1.5% | ||
| Q4 24 | 47.8% | 3.6% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 5.2% |
资本支出强度DOCHLF
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | 105.6% | 2.1% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 2.8% |
现金转化率DOCHLF
| Q1 26 | — | 1.86× | ||
| Q4 25 | 10.99× | 1.15× | ||
| Q3 25 | — | 3.21× | ||
| Q2 25 | 11.48× | 1.95× | ||
| Q1 25 | 6.52× | 0.00× | ||
| Q4 24 | 235.43× | 0.39× | ||
| Q3 24 | 3.71× | 2.10× | ||
| Q2 24 | 2.17× | 21.81× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
HLF
暂无分部数据
